Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 11
Submit an article Journal homepage
2,107
Views
49
CrossRef citations to date
0
Altmetric
Original Research

Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma

Chaoqi ZhangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Cancer center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Zhen ZhangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Feng LiBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Zhibo ShenBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Cancer center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Yamin QiaoDepartment of Pediatrics, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Lifeng LiBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Cancer center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Shasha LiuBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Cancer center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Mengjia SongBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Cancer center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Xuan ZhaoBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Feifei RenBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Qianyi HeBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Bo YangDepartment of Neurosurgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
,
Ruitai FanDepartment of Radiation Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaView further author information
&
Yi ZhangBiotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;Cancer center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China;School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450052, China;Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan450052, ChinaCorrespondence[email protected]
View further author information
 show all
Article: e1461304 | Received 26 Feb 2018, Accepted 30 Mar 2018, Published online: 23 Aug 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme.
Source: Public Library of Science (PLoS)

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.